share_log

藥明巨諾-B：股東週年大會通告

JW THERAP-B: NOTICE OF ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  Apr 25 18:53
Summary by Moomoo AI
藥明巨諾-B（股份代號：2126）將於2024年6月18日上午十時在中國上海浦東新區中科路699號B棟5層展示廳會議室召開股東週年大會。會議將處理包括接收及採納截至2023年12月31日止年度經審核綜合財務報表、董事會報告及核數師報告在內的事項。此外，會議還將重選李怡平醫生為執行董事，以及Sungwon Song博士、Krishnan Viswanadhan博士和Ann Li Lee博士為非執行董事，並授權董事會釐定董事薪酬。羅兵咸永道會計師事務所將被續聘為核數師，直至下屆股東週年大會結束。大會還將考慮通過授權董事在特定期間內配發新股份或購回股份的普通決議案，以及採納第九次經修訂及重述的組織章程大綱及細則的特別決議案。股份過戶登記將於2024年6月13日至6月18日暫停，以確定出席大會的股東資格。
藥明巨諾-B（股份代號：2126）將於2024年6月18日上午十時在中國上海浦東新區中科路699號B棟5層展示廳會議室召開股東週年大會。會議將處理包括接收及採納截至2023年12月31日止年度經審核綜合財務報表、董事會報告及核數師報告在內的事項。此外，會議還將重選李怡平醫生為執行董事，以及Sungwon Song博士、Krishnan Viswanadhan博士和Ann Li Lee博士為非執行董事，並授權董事會釐定董事薪酬。羅兵咸永道會計師事務所將被續聘為核數師，直至下屆股東週年大會結束。大會還將考慮通過授權董事在特定期間內配發新股份或購回股份的普通決議案，以及採納第九次經修訂及重述的組織章程大綱及細則的特別決議案。股份過戶登記將於2024年6月13日至6月18日暫停，以確定出席大會的股東資格。
Yauming Jelno-B (Stock Code: 2126) will hold its Annual General Meeting on 18 June 2024 at 10:00am in the Conference Room, 5-Floor Exhibition Hall B, 699 Zhongco Road, Pudong New District, Shanghai, China. The meeting will address matters including the receipt and adoption of the audited consolidated financial statements, Board reports and auditor's reports for the year ended 31 December 2023. In addition, the meeting will re-elect Dr. Lee Yi-ping as Executive Director and Dr. Sungwon Song, Dr. Krishnan Viswanadhan and Dr. Ann Li Lee as Non-Executive Directors, and authorize the Board to determine the remuneration of the Directors. Robing Hsiung Road Accounting Firm will be renewed as auditor until the end of the next Annual General Meeting. The General Meeting will...Show More
Yauming Jelno-B (Stock Code: 2126) will hold its Annual General Meeting on 18 June 2024 at 10:00am in the Conference Room, 5-Floor Exhibition Hall B, 699 Zhongco Road, Pudong New District, Shanghai, China. The meeting will address matters including the receipt and adoption of the audited consolidated financial statements, Board reports and auditor's reports for the year ended 31 December 2023. In addition, the meeting will re-elect Dr. Lee Yi-ping as Executive Director and Dr. Sungwon Song, Dr. Krishnan Viswanadhan and Dr. Ann Li Lee as Non-Executive Directors, and authorize the Board to determine the remuneration of the Directors. Robing Hsiung Road Accounting Firm will be renewed as auditor until the end of the next Annual General Meeting. The General Meeting will also consider the adoption of an ordinary resolution authorizing directors to issue new shares or repurchase shares within a specified period, as well as the adoption of a special resolution on the Ninth Revised and Revised Articles of Association and Conditions. Share transfer registration will be suspended from 13 June to 18 June 2024 to determine the eligibility of shareholders to attend the General Meeting.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more